Biogen announces job cuts, turns focus to Alzheimer’s drug launch
By Manas Mishra and Mariam Sunny (Reuters) -Biogen Inc said on Tuesday it expects to slash about 1,000 jobs, or 11% of its workforce, in a fresh round of cost-cutting as it looks to the launch of a new Alzheimer’s drug to help it return to growth. The company said its costs are elevated compared…
